Thermogenesis Holdings (THMO) could be worth how much in the next year?
What’s up with Thermogenesis Holdings?
Thermogenesis Holdings (THMO) opened at $11.01, which means the stock is down 4.48% from yesterday’s closing price of 10.94. Today, the company has a high of $11.36 and a low of $9.95. The company has a market cap of $60.28 million with a 52-week high of $14.18 and a 52-week low of $1.63.
What about the future for Thermogenesis Holdings?
The high forecast for Thermogenesis Holdings is $10.00 while the low is $5.00. Stock forecasts are based on human experience: Human traders based on their experience in terms of stock price patterns, volume changes, and market news/rumors regarding a particular stock. Thermogenesis Holdings has a weak forecast. A weak forecast is due to the company posting consistent losses in their earning reports. The future outlook does not seem too bright as this could potentially cause the company to file for bankruptcy. Based on this information THMO seems to be a risky buy.
About Thermogenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It operates through the Device and Clinical Development segment. The Device segment includes the development and commercialization of automated technologies for cell-based therapeutics and bioprocessing. The Clinical Development segment utilizes autologous stem cell-based therpeutics. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.